
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Aybintio | Bevacizumab | 2020-08-19 | ||
| Benepali | Etanercept | 2016-01-13 | ||
| Byooviz | Ranibizumab | 2021-09-17 | ||
| Eticovo | Etanercept | 2019-04-25 | ||
| Flixabi | Infliximab | 2016-05-26 | ||
| Hadlima | Adalimumab | 2019-07-23 | ||
| Imraldi | Adalimumab | 2017-08-24 | ||
| Onbevzi | Bevacizumab | 2021-01-11 | ||
| Ontruzant | Trastuzumab | 2019-01-18 | ||
| Renflexis | Infliximab | 2017-04-21 |
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|